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Abstract
Introduction: Uncalibrated arterial pulse power analysis has been recently introduced for continuous monitoring
of cardiac index (CI). The aim of the present study was to compare the accuracy of arterial pulse power analysis
with intermittent transpulmonary thermodilution (TPTD) before and after cardiopulmonary bypass (CPB).
Methods: Forty-two patients scheduled for elective coronary surgery were studied after induction of anaesthesia,
before and after CPB respectively. Each patient was monitored with the pulse contour cardiac output (PiCCO)
system, a central venous line and the recently introduced LiDCO monitoring system. Haemodynamic variables
included measurement of CI derived by transpulmonary thermodilution (CITPTD) or CI derived by pulse power
analysis (CIPP), before and after calibration (CIPPnon-cal.,C I PPcal.). Percentage changes of CI (ΔCITPTD, ΔCIPPnon-cal./PPcal.)
were calculated to analyse directional changes.
Results: Before CPB there was no significant correlation between CIPPnon-cal. and CITPTD (r
2 = 0.04, P = 0.08) with a
percentage error (PE) of 86%. Higher mean arterial pressure (MAP) values were significantly correlated with higher
CIPPnon-cal. (r
2 = 0.26, P < 0.0001). After CPB, CIPPcal. revealed a significant correlation compared with CITPTD (r
2 =
0.77, P < 0.0001) with PE of 28%. Changes in CIPPcal. (ΔCIPPcal.) showed a correlation with changes in CITPTD (ΔCITPTD)
only after CPB (r
2 = 0.52, P = 0.005).
Conclusions: Uncalibrated pulse power analysis was significantly influenced by MAP and was not able to reliably
measure CI compared with TPTD. Calibration improved accuracy, but pulse power analysis was still not consistently
interchangeable with TPTD. Only calibrated pulse power analysis was able to reliably track haemodynamic changes
and trends.
Introduction
Measuring left ventricular stroke volume and cardiac
index (CI) have gained increasing impact regarding peri-
operative monitoring of critically ill patients either in
the operating theatre or on the intensive care unit.
Goal-directed perioperative optimization of left ventricu-
lar stroke volume and CI have a positive impact on the
morbidity and the length of stay on the intensive care
unit [1-4]. Measurement of CI with the pulmonary
artery catheter (PAC) is still widely used and often
considered as a kind of “gold standard” in different clini-
cal settings [5,6]. However, several studies showed that
pulmonary artery catheterization has clinical limitations
and bares the potential risk for severe complications
[7-9]. In this context, interest has focused on less inva-
sive techniques which are based for example on trans-
pulmonary thermodilution (TPTD) or arterial waveform
analysis [6,10,11]. Alternative methods of haemodynamic
monitoring for estimating CI such as transpulmonary
thermodilution differ from pulmonary artery thermodi-
lution and are theoretically more sensitive to thermal
blood loss and changes such as recirculation and for-
ward-backward movement, especially in the presence of
left-sided valvular insufficiencies [12]. It has been
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modilution and transpulmonary thermodilution are
interchangeable in different patient populations and dur-
ing different surgical procedures [6,13-15].
T h er e c e n t l yi n t r o d u c e dL iDCO monitoring system
(LiDCORapid;L i D C OG r o u pL t d ,L o n d o n ,U K )c o n s i s t s
of an arterial pressure waveform analysis that provides
beat-to-beat measurement of CI by analysis of the arter-
ial blood pressure tracing. The underlying pulse power
algorithm (PulseCO) originally was introduced as an
algorithm requiring calibration by lithium indicator dilu-
tion to determine the individual vascular compliance
and has been evaluated in different clinical scenarios
[16,17]. Using a nomogram to assess the patient specific
aortic compliance, the new software version estimates
stroke volume without the need for calibration. Further-
more, this device offers the possibility of calibration by a
reference technique. Based on these updates, LiDCORa-
pid only requires a standard radial arterial line and is
claimed to mirror CI or trends of CI reliably. However,
calculation of cardiac index by arterial pressure wave-
form analysis could be influenced by several confoun-
ders, like changes in vascular tone or vasoactive drugs
[18,19]. Specifically, it has been shown that methods
based on arterial waveform analysis are prone to failure
after cardiopulmonary bypass (CPB), when major
changes in vascular resistance are likely to occur [15].
Therefore, the aim of the present study was to investi-
gate the accuracy of uncalibrated and calibrated pulse
power analysis (CIPPnon-cal.,C I PPcal.) with respect to
simultaneous measurements and the ability to track hae-
modynamic changes (ΔCITPTD, ΔCIPPnon-cal./cal.), both
before and after CPB.
Materials and methods
Approval from our institutional ethics committee
(Christian Albrecht University Kiel) was obtained and all
patients gave informed consent for participation in the
study.
Forty-two patients undergoing elective coronary artery
bypass grafting (CABG) were studied after induction of
general anaesthesia. Inclusion criteria were as follows:
patients >18 years of age with a left ventricular ejection
fraction ≥0.5. Patients with emergency procedures, hae-
modynamic instability requiring inotropic and/or
vasoactive pharmacologic support, intracardiac shunts,
severe aortic-, tricuspid- or mitral stenosis or insuffi-
ciency, and patients on an intra-aortic balloon pump
were all excluded from the study.
Instrumentation and protocol
All patients were pre-medicated with midazolam 0.1
mg·kg
-1 orally 30 minutes before induction of anaesthe-
sia. Routine monitoring was established including non-
invasive blood pressure (NIBP), peripheral oxygen
saturation (SpO2) and heart rate (HR) by electrocardio-
gram (ECG; S/5, GE Healthcare, Helsinki, Finland). Sub-
sequently patients received a peripheral venous access
and a radial arterial pressure catheter. The LiDCORapid
monitor was connected to the S/5 monitor and started
after input of patient specific data according to the man-
ufacturer’s instructions. After induction of anaesthesia
with sufentanil (0.5 μg·kg
-1) and propofol (1.5 mg·kg
-1),
orotracheal intubation was facilitated with rocuronium
(0.6 mg·kg
-1). Anaesthesia was maintained with sufenta-
nil (1 μg·kg
-1·h
-1) and propofol (3 mg·kg
-1·h
-1). Patients
were ventilated with an oxygen/air mixture using a tidal
volume of 8 ml·kg
-1 and positive end-expiratory pressure
was set at 5 cmH₂O. A central venous catheter and a
thermodilution catheter (Pulsion Medical Systems,
Munich, Germany) were introduced in the right internal
jugular vein, respectively in the femoral artery and the
thermodilution catheter was connected to the PiCCO
monitor (PiCCOplus, software version 6.0; Pulsion Med-
ical Systems, Munich, Germany).
Data collection
Measurements of CITPTD were performed every 15 min-
utes by injecting 15 ml ice cold saline (≤8°C) through
the central venous line. Injections were repeated at least
three times and randomly assigned to the respiratory
cycle. In case of a difference with respect to the preced-
ing CITPTD measurement of ≥15%, the value obtained
was discarded and the measurement repeated. Measure-
ments of CIPP were performed by plotting 10 numerical
values over a period of one minute, excluding variations
≥15% and determining the mean value. Mean arterial
pressure and CVP were also recorded every 15 minutes.
Values of CIPPnon-cal.,a n dC I PPcal. were collected during
a one minute period and averaged. After induction of
anaesthesia, haemodynamic variables including CITPTD
and CIPPnon-cal. were recorded every 15 minutes up to
30 minutes (T1), which means two pairs of measure-
ments. After 30 minutes, calibration of pulse power ana-
lysis (CIPPcal.) was performed and measurements were
recorded until the beginning of CPB (T2), which dif-
fered from patient to patient yielding different numbers
of measurements in this time period. Measurements
were restarted 15 minutes after weaning from CPB. Sub-
sequently, measurements of CITPTD and CIPPnon-cal. were
obtained up to 45 minutes (T3), yielding three pairs of
measurements. After 45 minutes, re-calibration of pulse
power analysis (CIPPcal.)w a sc a r r i e do u ta n dh a e m o d y -
namic variables were recorded until the patient was dis-
charged to the intensive care unit (T4), again yielding a
different number of measurement pairs in individual
patients. Two patients were discharged to the intensive
care unit 45 minutes after CPB, therefore, CIPPcal.
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The study design is displayed in Figure 1.
Statistical analysis
All data are given as mean ± SD. Statistical comparisons
were performed using commercially available statistics
software (GraphPad Prism 5, GraphPad Software Inc.,
San Diego, CA, USA, Software R, R Foundation for Sta-
tistical Computing, Vienna, Austria and PASS Version
1 1 ,N C S S ,L L C .K a y s v i l l e ,U T ,U S A ) .T od e m o n s t r a t e
the relationship between sample size and the width of
the confidence interval of the estimated variable, we cal-
culated the width of the 95% confidence interval of the
limits of agreement (0.52 standard deviations of the
bias). To describe the agreement between CITPTD, CIPP-
non-cal. and CIPPcal., Bland-Altman plots were calculated
for each time period (T1 to T4) before and after CPB.
Percentage error was calculated as described by Critch-
ley and colleagues, using the limits of agreement (2SD)
of the bias divided by the mean CI values from CITPTD,
CIPPnon-cal. and CIPPcal.. Bland-Altman plots were also
performed for haemodynamic trends (ΔCITPTD, ΔCIPP-
non-cal. and ΔCIPPcal.) before and after CPB. ΔCITPTD
<15% were excluded from analysis as recommended by
Critchley and co-workers [20]. To describe the discrimi-
native power of ΔCIPPnon-cal. and ΔCIPPcal. predicting
true changes in CITPTD (>15%) ROC analysis was per-
formed. Post hoc power of ROC analysis was calculated
with PASS software. Dependent upon the number of
subjects enrolled at each time point (T1 to T4) the dif-
ference with respect to AUC between the null hypoth-
esis (AUC = 0.50) and the alternative hypothesis (AUC
of ΔCIPPnon-cal. and ΔCIPPcal. >0.50) that could be
detected ranged from 0.28 to 0.32 for an a = 0.05 and a
b = 0.20. An unpaired sample t-test was used to analyse
significant differences of mean arterial pressure related
to the periods of measurement.
Results
Data from all 42 patients, 31 males and 11 females, were
included in the final analysis. Ages ranged between 41
to 78 years, with a mean age of 63 ± 5 and a mean body
m a s si n d e xo f2 7 . 4±4 . 9k g / m
2. Mean left ventricular
ejection fraction was 0.58 ± 0.04%. A total of 430 data
pairs (T1: 84, T2: 164, T3: 123, T4: 59) were obtained
during the study period. An unpaired t-test showed a
significant difference (P <0 . 0 5 )b e t w e e nM A Pv a l u e s
before (T1, T2) and after cardiopulmonary bypass (T3,
T4). Haemodynamic and respiratory variables are shown
in Table 1.
There was no significant correlation between CIPPnon-
cal. and CITPTD (r
2 = 0.04, P = 0.08, n = 84) within
the first 30 minutes (T1) after induction of anaesthesia
(Figure 2). Bland-Altman analysis showed a mean bias
of 0.36 L/minute/m
2 (95% limits of agreement (LOA):
-1.73 to +2.46 L/minute/m
2) with a percentage error
(PE) of 86%. Bias, LOA and PE for each time period (T1
to T4) are summarized in Table 2. Correlation between
Figure 1 Study design. T1: data collection after induction of anaesthesia until calibration (CIPPnon-cal.). T2: after calibration until cardiopulmonary
bypass (CIPPcal.). T3: after cardiopulmonary bypass until calibration (CIPPnon-cal.). T4: after calibration until discharge to the intensive care unit
(CIPPcal.).
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revealed a significant correlation with CITPTD (r
2 = 0.42,
P < 0.0001, n = 164) and Bland-Altman analysis showed
a mean bias of 0.075 L/minute
1/m
2 (LOA: -1.19 to +
1.34 L/minute/m
2) with a PE of 55%. A significant
correlation (r
2 = 0.30, P < 0.0001, n = 123) between
CIPPnon-cal. and CITPTD was observed after weaning from
CPB (T3) with a mean bias of 0.0078 L/minute/m
2
(LOA: -1.69 to + 1.68 L/minute/m
2) and an overall PE
of 51%. After 45 minutes (T4), pulse power calibration
Table 1 Haemodynamic and respiratory variables at different time points
Pre - Bypass Post - Bypass
Variables Time points Data pairs T1 n = 84 T2 n = 164 P T3 n = 123 T4 n = 59 P
HR (minute
-1) 55 ± 2 56 ± 3 PP= 0.45 80 ± 3
§ 82 ± 2
§ PP= 0.33
MAP (mmHg) 83 ± 17 76 ± 12 P <0.05 68 ± 7
§ 67 ± 5
§ P = 0.98
CVP (mmHg) 10 ± 2 11 ± 2 P = 0.54 9 ± 1 11 ± 1 P0= 0.10
Lung compliance (mL/cmH2O) 51 ± 2 53 ± 1 P = 0.22 50 ± 2 49 ± 2 P = 0.67
Tidal volume (mL) 675 ± 75 686 ± 69 P = 0.15 700 ± 72 695 ± 70 P = 0.39
SVRI (dynes∙s/cm
5/m
2) 2,712 ± 68 2,096 ± 327 P <0.05 1,659 ± 141
§ 1 729 ± 138
§ P = 0.11
CIPPnon-cal. (L/minute/m
2) 2.5 ± 0.7 3.4 ± 0.2 *
CIPPcal. (L/minute/m
2) 2.6 ± 0.2 3.2 ± 0.1
#
CITPTD (L/minute/m
2) 2.3 ± 0.1 2.4 ± 0.1 P = 0.17 3.3 ± 0.2
§ 3.3 ± 0.2
§ P = 0.55
HR, heart rate; MAP, mean arterial HR, heart.
CIPPnon-cal., cardiac index by uncalibrated pulse power analysis; CIPPcal., cardiac index by calibrated pulse power analysis; CITPTD, cardiac index by transpulmonary
thermodilution; CVP, central venous pressure; HR, heart rate; MAP, mean arterial pressure, stroke volume index by transpulmonary thermodilution; SVRI, systemic
vascular resistance index; SVITPTD. Values are given as mean ± SD.
§P < 0.05 (vs. T1, T2), *P < 0.05 (vs. T1),
# P < 0.05 (vs. T2).
Figure 2 Correlation of cardiac indices before (T1, T2) and after (T3, T4) cardiopulmonary bypass.
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tion to CITPTD (r
2 = 0.77, P < 0.0001, n = 59) with a
mean bias of 0.0071 L/minute/m
2,L O Af r o m- 0 . 8 9t o
+0.91 L/minute/m
2 and an overall PE of 28%.
Trends of percentage changes in CI measured by pulse
power analysis (ΔCIPPnon-cal., ΔCIPPcal) and transpulmonary
thermodilution (ΔCITPTD) are presented in detail (see
Additional file 1, Figure S1). Bland-Altman analysis showed
a significant correlation for ΔCIPPnon-cal. and ΔCITPTD (r
2 =
0.27, P = 0.003) in T1 with LOA from -62 to 67%. After
calibration (T2), correlation between ΔCIPPcal. and
ΔCITPTD again was statistically significant (r
2 = 0.30,
P <0.0001), with LOA ranging from -42 to 36%. In time
period 3 after weaning from CPB, ΔCIPPnon-cal. correlated
with ΔCITPTD (r
2 =0 . 1 8 ,P = 0.01, LOA of -56 to 56%).
After calibration (T4), ΔCIPPcal. indicated a statistically sig-
nificant association (r
2 = 0.52, P = 0.005) with ΔCITPTD
a n ds h o w e dL O Af r o m- 2 0t o1 9 % .R e s u l t sf r o mR O Ca n a -
lysis showing the ability of ΔCIPPnon-cal. and ΔCIPPcal. to
predict a ΔCITPTD >15% are available (see Additional file 1,
Table S1). Only ΔCIPPcal. was able to predict ΔCITPTD
>15% with a sensitivity of 90% and a specificity of 80%
(AUC: 0.83, P =0 . 0 3 ) .
Correlation between MAP, CIPPnon-cal. and CIPPcal.,
before and after CPB is illustrated in Figure 3. Before CPB
(T1), higher MAP values were significantly associated with
higher CIPPnon-cal. (r
2 =0 . 2 6 ,P <0.0001). CITPTD showed
no correlation with MAP before (r
2 <0 . 0 1 ,P = 0.46) and
after (r
2 = 0.03, P = 0.05) CPB. There was no significant
relationship between CIPPnon-cal. and systemic vascular
resistance (T1: r
2 = 0.004, P = 0.49; T2: r
2 = 0.02, P =0 . 1 1 ;
T3 r
2 =0 . 0 2 ,P =0 . 1 0 ,T 4r
2 =0 . 0 1 ,P = 0.37) during the
whole study period (T1 to T4).
Discussion
The main findings of the present investigation is that CI
measurement by uncalibrated arterial pulse power analy-
sis was not able to reliably measure CI compared with
TPTD before and after CPB. After calibrating the pulse
power algorithm with TPTD, PE was acceptable (<30%)
after CPB. In a subset of the observed patients before
CPB, higher MAP values showed a significant relation-
ship with CIPPnon-cal..
Arterial pulse power analysis for continuous CI mea-
surement was introduced several years ago. Until
recently, this system required a lithium indicator dilu-
tion in order to calibrate for individual aortic compli-
ance. The new monitoring system LiDCORapid has been
developed to provide continuous CI measurement with-
out the need for calibration by using patient specific
data for estimation of arterial compliance. To the best
of our knowledge this is the first study analysing the
accuracy of uncalibrated and calibrated pulse power
analysis in patients undergoing coronary artery surgery.
Applying criteria proposed by Critchley and colleagues
[21] to compare a new method of CI measurement with
an established one, we regarded the pulse power analysis
method as not interchangeable with the reference
method (TPTD) if the percentage error exceeded 30%.
During the first 30 minutes after induction of anaesthe-
sia we found no correlation between CIPPnon-cal. and
CITPTD and obtained a percentage error of 86%. This
value is considerably above the 30% limit of interchan-
geability and illustrates the difference we observed dur-
ing the first period of time. To determine the influence
of calibration, pulse power analysis was calibrated at
defined time points before and after cardiopulmonary
bypass by transpulmonary thermodilution. Accordingly,
calibration should lead to an adequate accuracy and pre-
cision with respect to the reference technique, at least in
the immediate period following calibration. In this con-
text, we did not record continous cardiac output gener-
ated by the PiCCO monitoring system (PCCO), because
due to our repeated calibrations we would have obtained
a perfect PCCO (calibrated to the actual aortic impe-
dance every 15 minutes by transpulmonary thermodilu-
tion), which would have induced a large bias in favor of
PCCO. Several studies could demonstrate a less reliable
measurement of CO by PCCO in patients undergoing
cardiac surgery and in the presence of low vascular
resistance after a longer period of time had elapsed after
the last calibration [10,22,23].
Table 2 Bland-Altman analysis showing 95% limits of agreement, confidence interval and percentage error
T1 T2 T3 T4
ndata/npatient n = 84/n = 42 n = 164/n = 42 n = 123/n = 42 n = 59/n = 40
CIPPnon-cal. CIPPcal. CIPPnon-cal. CIPPcal.
Mean (L/minute/m
2) 2.47 2.33 3.35 3.24
Bias (L/minute/m
2) 0.36 0.075 0.0078 0.0071
SD of bias (L/minute/m
2) 1.07 0.65 0.86 0.46
CI of LOA (L/minute/m
2) 0.56 0.34 0.45 0.24
95% Limits of agreement (L/minute/m
2) -1.73 to +2.46 -1.19 to +1.34 -1.69 to +1.68 -0.89 to +0.91
Percentage error (%) 86 55 51 28
CIPPnon-cal., cardiac index by uncalibrated pulse power analysis; CIPPcal., cardiac index by calibrated pulse power analysis; CITPTD, cardiac index by transpulmonary
thermodilution, CI of LOA, confidence interval of the limits of agreement; Values are given as mean ± SD.
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between CIPPcal. and CITPTD (r
2 =0 . 4 2 ,P < 0.0001) at T2
after pulse power calibration before CPB, PE was 55%,
clearly exceeding the 30% limit mentioned before. After
cardiopulmonary bypass, CIPPnon-cal. and CIPPcal. once
again showed a significant correlation with CITPTD and PE
was 51% and 28%. As recommended by recent literature,
we calculated the precision of CIPPnon-cal./cal. before and
after CPB [24] and obtained a sufficient precision confirm-
ing our personal experience as we observed no rapid
changes in CI during data recording. An explanation of
these results can be found in the method underlying unca-
librated arterial pulse wave analysis. The physiological
foundation of arterial pressure curves is the proportional
relation of aortic pulse pressure and stroke volume and
their inverse relation to aortic compliance [25,26]. Based
on the windkessel model by Otto Frank arterial waveform
analysis is influenced by three vascular properties: resis-
tance, compliance and impedance [27]. However, several
confounders such as individual changes in vascular com-
pliance and resistance [28], gender [29] or vascular dis-
eases [30] may influence this relationship in an unforeseen
way. Recently, detrimental influence of significant changes
of blood pressure on the accuracy of uncalibrated
waveform analysis was reported both in animals and
humans [25,31]. Because of the individually different rela-
tionship between changes in aortic compliance and
changes in stroke volume, the increased arterial waveform
could be inadvertently misinterpreted as an increase in
stroke volume [32]. In accordance, we could demonstrate
a significant correlation between MAP and CIPPnon-cal. (r
2
= 0.26, P < 0.0001) at T1, meaning that higher MAP values
were associated with higher CIPPnon-cal. values. It must be
noted, however, that this correlation is based on few data
points from a small number of patients observed in T1.
Additionally, the absence of correlation between MAP and
CITPTD emphasizes the fact that arterial compliance dif-
fered from patient to patient. As mentioned above, aortic
compliance is linked to a non-linear response to arterial
pressure and since the individual aortic cross sectional
area is unknown, these uncertainties could lead to impre-
cision in determination of cardiac index by arterial wave-
form analysis. Therefore, this emphasizes the use of
thermodilution to provide maximum accuracy during hae-
modynamic measurements.
Changes of systemic vascular resistance during surgery
or intensive care therapy are caused by various factors
such as temperature, fluid administration or decreased
Figure 3 Correlation between cardiac index (CI) and mean arterial pressure (MAP) before (T1 to 2) and after (T3 to 4)
cardiopulmonary bypass.
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cant lower systemic vascular resistance index (P <0 . 0 5 )
after weaning from CPB but found no correlation
between CITPTD,C I PPnon-cal./cal. and systemic vascular
resistance before and after CPB. In contrast to our find-
ings, other observations recently reported a significant
negative impact on the accuracy of arterial pulse wave
analysis in patients with septic shock [33,34] and due to
changes in vascular tone by vasoactive agents or intra-
peritoneal hypertension [19,35]. To avoid misinterpreta-
tion in the presence of disturbing factors and to achieve
the required precision, monitoring systems based on
arterial waveform analysis should be able to recalculate
arterial compliance at short intervals [32]. In this con-
text, the frequency of recalculation and the underlying
algorithm of uncalibrated pulse power analysis have not
yet been published.
Besides the acquisition of exact CI data, the LiDCORa-
pid monitoring system was also developed for evaluation
and reflection of haemodynamic changes and trends dur-
ing the perioperative period. In case of a critically ill
patient, physicians are advised by the manufacturer to
calibrate the system. Many patients undergoing elective
major surgical procedures exhibit several co-morbidities,
such as coronary artery disease and organ dysfunction
without being in a life-threatening condition. Accord-
ingly, with respect to this patient population most clini-
cians are more interested in perioperative haemodynamic
changes or trends than intermittent absolute CI values.
Furthermore, to avoid misleading interpretation of the
Bland-Altman analysis, trends of percentage changes in
CI were calculated [36] and changes of CI obtained by
transpulmonary thermodilution <15% were excluded
from further analysis as noise [20].
In our study, trends of percentage changes in CI mea-
sured by pulse power analysis (ΔCIPPnon-cal./PPcal.)a n d
transpulmonary thermodilution (ΔCITPTD) revealed a
weak but significant correlation before and after CPB.
Calibration of pulse power analysis improved statistical
significance, as well as the measurements obtained at
lower MAP values immediately after CPB. We observed
the best correlation of changes in CI between transpul-
monary thermodilution and pulse power analysis after
CPB and calibration; however, the patient sample was
limited at T4 and, therefore, these data should be inter-
preted with caution. However, ROC analysis for predic-
tion of ΔCITPTD >15% showed that only ΔCIPPcal. was
able to track haemodynamic changes and trends with
sufficient sensitivity and specificity.
Some limitations of our study must be noted. We
investigated a monitoring system developed to reflect
haemodynamic trends, rather than measuring accurate
CI. However, a prerequisite for using a system to guide
goal-directed haemodynamic therapy in clinical settings
is to understand the precision and the limitation of a
monitoring technique. Furthermore, transpulmonary
thermodilution implies some limitations particularly
after weaning from cardiopulmonary bypass with
ongoing thermal changes, leading to a higher bias
caused by reduced accuracy of the reference technique
[10]. However, we observed better correlation between
CI and trends of CI by transpulmonary thermodilution
a n dc a l i b r a t e dp u l s ep o w e ra n a l y s i sa f t e rw e a n i n gf r o m
CPB. Due to the fact that we did not assess CI by unca-
librated and calibrated pulse power analysis at the same
time but under different haemodynamic conditions, this
could have induced a small bias especially in the
immediate period following CPB. In this context, CIPP is
probably also influenced by systolic arterial pressure
which was unfortunately not recorded during the study
period. Finally, we excluded patients with haemody-
namic instability or shock and investigated patients
undergoing elective coronary surgery with normal left
ventricular function and without continuous application
of vasoactive drugs. Therefore, our results cannot be
extrapolated to patients with impaired left ventricular
function, low cardiac output or patients receiving ino-
tropic or vasoactive support.
Conclusions
With respect to the absolute values of CI measurement,
the less invasive technique of uncalibrated pulse power
analysis was not interchangeable with transpulmonary
thermodilution, both before and after CPB. Calibration
of pulse power analysis improved accuracy, but PE was
only acceptable after CPB. Correlation between MAP
and CIPPnon-cal. in a subset of patients at T1 suggests
that in the presence of high blood pressure, data from
uncalibrated pulse power analysis should probably be
interpreted with caution. Only calibrated pulse power
analysis was able to reliably track haemodynamic
changes and trends. As only a homogeneous elective
patient collective was investigated, the present results,
however, cannot be generalized and transferred to other
groups of patients.
Key messages
• Uncalibrated pulse power analysis was not inter-
changeable with transpulmonary thermodilution
before and after CPB.
• Calibration improved accuracy, but pulse power
analysis was still not consistently interchangeable
with transpulmonary thermodilution.
• Only calibrated pulse power analysis was able to
track the percentage of changes in CI measured by
transpulmonary thermodilution.
• Uncalibrated pulse power analysis was significantly
influenced by MAP in a subset of the observed
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Page 7 of 9patients, requiring further investigation in different
patient populations.
Additional material
Additional file 1: Figure S1 and Table S1. Figure S1: Correlation of
changes in cardiac index (ΔCI). Correlation and Bland-Altman analysis of
changes (%) in cardiac index (ΔCI) measured by pulse power analysis
(ΔCIPP) and transpulmonary thermodilution (ΔCITPTD) before (T1 to 2) and
after (T3 to 4) cardiopulmonary bypass. Table S1: ROC-analysis to predict
a change in CI by TPTD (ΔCITPTD) >15%. Area under the Receiver
Operating Characteristic Curve showing the ability of uncalibrated and
calibrated pulse power analysis to predict a change in CI by TPTD
(ΔCITPTD) >15%.
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